Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Degenerative and Vascular Fluent Aphasia: Looking for Differences.

Silveri MC, Di Tella S, Magni E, Pepe F, Leone E, Piludu F, Colosimo C, Ciccarelli N.

Cogn Behav Neurol. 2019 Dec;32(4):225-235. doi: 10.1097/WNN.0000000000000207.

PMID:
31800483
2.

Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?

Ciccarelli N.

Infection. 2020 Feb;48(1):37-42. doi: 10.1007/s15010-019-01373-8. Epub 2019 Nov 6. Review.

PMID:
31691905
3.

Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population.

Ciccarelli N, Baldonero E, Milanini B, Fabbiani M, Cauda R, Di Giambenedetto S, Silveri MC.

Infez Med. 2019 Sep 1;27(3):274-282.

4.

Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.

Fabbiani M, Ciccarelli N, Castelli V, Soria A, Borghetti A, Colella E, Moschese D, Valsecchi M, Emiliozzi A, Gori A, De Luca A, Bandera A, Di Giambenedetto S.

J Neurovirol. 2019 Dec;25(6):866-873. doi: 10.1007/s13365-019-00780-9. Epub 2019 Jul 7.

PMID:
31281946
5.

Emotional valence may influence memory performance for visual artworks in Parkinson's disease.

Ciccarelli N, Di Tella S, Lo Monaco MR, Carfì A, Serafini E, Delle Donne V, Silveri MC.

Neurol Sci. 2019 Oct;40(10):2175-2178. doi: 10.1007/s10072-019-03939-8. Epub 2019 May 29.

PMID:
31144156
6.

Liver fibrosis is associated with cognitive impairment in people living with HIV.

Ciccarelli N, Fabbiani M, Brita AC, De Marco R, Grima P, Gagliardini R, Borghetti A, Cauda R, Di Giambenedetto S.

Infection. 2019 Aug;47(4):589-593. doi: 10.1007/s15010-019-01284-8. Epub 2019 Feb 19.

PMID:
30784024
7.

SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV.

Borghetti A, Calcagno A, Lombardi F, Cusato J, Belmonti S, D'Avolio A, Ciccarelli N, La Monica S, Colafigli M, Delle Donne V, De Marco R, Tamburrini E, Visconti E, Di Perri G, De Luca A, Bonora S, Di Giambenedetto S.

J Antimicrob Chemother. 2019 Apr 1;74(4):1035-1043. doi: 10.1093/jac/dky508.

PMID:
30561642
8.

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.

Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group.

J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123.

PMID:
29668978
9.

Informal Caregiving, Employment Status and Work Hours of the 50+ Population in Europe.

Ciccarelli N, Van Soest A.

Economist (Leiden). 2018;166(3):363-396. doi: 10.1007/s10645-018-9323-1. Epub 2018 May 31.

10.

The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease.

Ciccarelli N, Monaco MRL, Fusco D, Vetrano DL, Zuccalà G, Bernabei R, Brandi V, Pisciotta MS, Silveri MC.

Aging Clin Exp Res. 2018 Jul;30(7):877-880. doi: 10.1007/s40520-017-0838-0. Epub 2017 Oct 11.

PMID:
29019160
11.

Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA.

Rossetti B, Meini G, Bianco C, Lamonica S, Mondi A, Belmonti S, Fanti I, Ciccarelli N, Di Giambenedetto S, Zazzi M, De Luca A.

J Clin Virol. 2017 Jun;91:18-24. doi: 10.1016/j.jcv.2017.03.018. Epub 2017 Mar 23.

PMID:
28395180
12.

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).

Di Giambenedetto S, Fabbiani M, Quiros Roldan E, Latini A, D'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Di Pietro M, Mondi A, Ciccarelli N, Borghetti A, Focà E, Colafigli M, De Luca A, Cauda R; Atlas-M Study Group.

J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557.

PMID:
28093483
13.

Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS.

Ciccarelli N, Limiti S, Fabbiani M, Baldonero E, Milanini B, Lamonica S, Cauda R, Di Giambenedetto S, Silveri MC.

Appl Neuropsychol Adult. 2017 Sep-Oct;24(5):410-419. doi: 10.1080/23279095.2016.1189424. Epub 2016 Jun 13.

PMID:
27292092
14.

Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).

Milanini B, Ciccarelli N, Fabbiani M, Baldonero E, Limiti S, Gagliardini R, Borghetti A, D'Avino A, Mondi A, Colafigli M, Cauda R, Di Giambenedetto S.

Clin Neuropsychol. 2016 Jan-Dec;30(sup1):1457-1468. Epub 2016 May 16.

PMID:
27180611
15.

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy.

Borghetti A, Baldin G, Ciccullo A, Gagliardini R, D'Avino A, Mondi A, Ciccarelli N, Lamonica S, Fanti I, Trecarichi E, Fabbiani M, Cauda R, De Luca A, Di Giambenedetto S.

J Antimicrob Chemother. 2016 Aug;71(8):2359-61. doi: 10.1093/jac/dkw147. Epub 2016 May 4. No abstract available.

PMID:
27147306
16.

Cognitive reserve and neuropsychological functioning in older HIV-infected people.

Milanini B, Ciccarelli N, Fabbiani M, Limiti S, Grima P, Rossetti B, Visconti E, Tamburrini E, Cauda R, Di Giambenedetto S.

J Neurovirol. 2016 Oct;22(5):575-583. Epub 2016 Mar 10.

PMID:
26965299
17.

Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.

Mondi A, Fabbiani M, Ciccarelli N, Colafigli M, D'Avino A, Borghetti A, Gagliardini R, Cauda R, De Luca A, Di Giambenedetto S.

J Antimicrob Chemother. 2015;70(6):1843-9. doi: 10.1093/jac/dkv037. Epub 2015 Feb 26.

PMID:
25885326
18.

Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.

Fabbiani M, Grima P, Milanini B, Mondi A, Baldonero E, Ciccarelli N, Cauda R, Silveri MC, De Luca A, Di Giambenedetto S.

Antivir Ther. 2015;20(4):441-7. doi: 10.3851/IMP2926. Epub 2014 Dec 17.

PMID:
25516553
19.

Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients.

Ciccarelli N, Grima P, Fabbiani M, Baldonero E, Borghetti A, Milanini B, Limiti S, Colafigli M, Tamburrini E, Cauda R, De Luca A, Di Giambenedetto S.

Antivir Ther. 2015;20(4):433-40. doi: 10.3851/IMP2925. Epub 2014 Dec 11.

PMID:
25504667
20.

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre.

Borghetti A, Mondi A, Piccoli B, Gagliardini R, Lamonica S, Ciccarelli N, D'Avino A, Pallavicini F, Cauda R, De Luca A, Fabbiani M, Di Giambenedetto S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19817. doi: 10.7448/IAS.17.4.19817. eCollection 2014.

21.

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA.

Bianco C, Meini G, Rossetti B, Lamonica S, Mondi A, Belmonti S, Fanti L, Ciccarelli N, Di Giambenedetto S, Zazzi M, De Luca A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19791. doi: 10.7448/IAS.17.4.19791. eCollection 2014.

22.

Liver fibrosis is associated with cognitive impairment in HIV-positive patients.

Ciccarelli N, Fabbiani M, Grima P, Limiti S, Fanti I, Mondi A, Gagliardini R, D'Avino A, Borghetti A, Cauda R, Di Giambenedetto S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19722. doi: 10.7448/IAS.17.4.19722. eCollection 2014.

23.

Posterior AD-type pathology: cognitive subtypes emerging from a cluster analysis.

Cappa A, Ciccarelli N, Baldonero E, Martelli M, Silveri MC.

Behav Neurol. 2014;2014:259358. doi: 10.1155/2014/259358. Epub 2014 Jun 5.

24.

Primary progressive aphasia: linguistic patterns and clinical variants.

Silveri MC, Pravatà E, Brita AC, Improta E, Ciccarelli N, Rossi P, Colosimo C.

Brain Lang. 2014 Aug;135:57-65. doi: 10.1016/j.bandl.2014.05.004. Epub 2014 Jun 27.

PMID:
24974082
25.

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study).

Fabbiani M, Mondi A, Colafigli M, D'Ettorre G, Paoletti F, D'Avino A, Ciccarelli N, Sidella L, Murri R, Fortuna S, Vullo V, Cauda R, De Luca A, Di Giambenedetto S.

Scand J Infect Dis. 2014 Jan;46(1):34-45. doi: 10.3109/00365548.2013.840920. Epub 2013 Oct 28.

PMID:
24161018
26.

Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.

Ciccarelli N, Fabbiani M, Grima P, Falasca K, Tana M, Baldonero E, Colafigli M, Silveri MC, Vecchiet J, Cauda R, Di Giambenedetto S.

Infection. 2013 Dec;41(6):1103-9. doi: 10.1007/s15010-013-0503-2. Epub 2013 Jul 10.

PMID:
23839213
27.

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.

Ciccarelli N, Fabbiani M, Colafigli M, Trecarichi EM, Silveri MC, Cauda R, Murri R, De Luca A, Di Giambenedetto S.

Antivir Ther. 2013;18(2):153-60. doi: 10.3851/IMP2560. Epub 2013 Mar 13.

PMID:
23486721
28.

Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).

Di Giambenedetto S, Fabbiani M, Colafigli M, Ciccarelli N, Farina S, Sidella L, D'Avino A, Mondi A, Cingolani A, Tamburrini E, Murri R, Navarra P, Cauda R, De Luca A.

J Antimicrob Chemother. 2013 Jun;68(6):1364-72. doi: 10.1093/jac/dkt007. Epub 2013 Jan 30.

PMID:
23372058
29.

Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance.

Baldonero E, Ciccarelli N, Fabbiani M, Colafigli M, Improta E, D'Avino A, Mondi A, Cauda R, Di Giambenedetto S, Silveri MC.

BMC Psychol. 2013 Feb 27;1(1):3. doi: 10.1186/2050-7283-1-3. eCollection 2013.

30.

Effect of aging and human immunodeficiency virus infection on cognitive abilities.

Ciccarelli N, Fabbiani M, Baldonero E, Fanti I, Cauda R, Di Giambenedetto S, Silveri MC.

J Am Geriatr Soc. 2012 Nov;60(11):2048-55. doi: 10.1111/j.1532-5415.2012.04213.x. Epub 2012 Oct 30.

PMID:
23110543
31.

Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients.

Fabbiani M, Ciccarelli N, Tana M, Farina S, Baldonero E, Di Cristo V, Colafigli M, Tamburrini E, Cauda R, Silveri MC, Grima P, Di Giambenedetto S.

HIV Med. 2013 Mar;14(3):136-44. doi: 10.1111/j.1468-1293.2012.01044.x. Epub 2012 Sep 21.

32.

Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.

Grima P, Fabbiani M, Ciccarelli N, Tana M, Farina S, Colafigli M, Mondi A, Cauda R, Di Giambenedetto S.

J Infect. 2012 Nov;65(5):439-46. doi: 10.1016/j.jinf.2012.07.005. Epub 2012 Aug 3.

PMID:
22863903
33.

Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease.

Silveri MC, Ciccarelli N, Baldonero E, Piano C, Zinno M, Soleti F, Bentivoglio AR, Albanese A, Daniele A.

Neuropsychologia. 2012 Jul;50(8):1980-9. doi: 10.1016/j.neuropsychologia.2012.04.023. Epub 2012 May 7.

PMID:
22575085
34.

Unilateral spatial neglect in degenerative brain pathology.

Silveri MC, Ciccarelli N, Cappa A.

Neuropsychology. 2011 Sep;25(5):554-66. doi: 10.1037/a0023957.

PMID:
21639641
35.

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E, Cauda R, De Luca A, Silveri MC.

Neurology. 2011 Apr 19;76(16):1403-9. doi: 10.1212/WNL.0b013e31821670fb.

PMID:
21502598
36.

Therapeutic potential of plasma gelsolin administration in a rat model of sepsis.

Cohen TS, Bucki R, Byfield FJ, Ciccarelli NJ, Rosenberg B, DiNubile MJ, Janmey PA, Margulies SS.

Cytokine. 2011 Jun;54(3):235-8. doi: 10.1016/j.cyto.2011.02.006. Epub 2011 Mar 21.

37.

Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis.

Kułakowska A, Zajkowska JM, Ciccarelli NJ, Mroczko B, Drozdowski W, Bucki R.

Neurodegener Dis. 2011;8(5):375-80. doi: 10.1159/000324373. Epub 2011 Mar 10.

38.

Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis.

Kułakowska A, Ciccarelli NJ, Wen Q, Mroczko B, Drozdowski W, Szmitkowski M, Janmey PA, Bucki R.

BMC Neurol. 2010 Nov 1;10:107. doi: 10.1186/1471-2377-10-107.

39.

Plasma gelsolin modulates cellular response to sphingosine 1-phosphate.

Bucki R, Kulakowska A, Byfield FJ, Zendzian-Piotrowska M, Baranowski M, Marzec M, Winer JP, Ciccarelli NJ, Górski J, Drozdowski W, Bittman R, Janmey PA.

Am J Physiol Cell Physiol. 2010 Dec;299(6):C1516-23. doi: 10.1152/ajpcell.00051.2010. Epub 2010 Sep 1.

40.

Semantic memory in object use.

Silveri MC, Ciccarelli N.

Neuropsychologia. 2009 Oct;47(12):2634-41. doi: 10.1016/j.neuropsychologia.2009.05.013. Epub 2009 May 29.

PMID:
19482039
42.

The deficit for the word-class "verb" in corticobasal degeneration: linguistic expression of the movement disorder?

Silveri MC, Ciccarelli N.

Neuropsychologia. 2007 Jun 18;45(11):2570-9. Epub 2007 Mar 23.

PMID:
17467749
43.
44.

Sibship size, birth order, and atopy in 11,371 Italian young men.

Matricardi PM, Franzinelli F, Franco A, Caprio G, Murru F, Cioffi D, Ferrigno L, Palermo A, Ciccarelli N, Rosmini F.

J Allergy Clin Immunol. 1998 Apr;101(4 Pt 1):439-44.

PMID:
9564794
45.

Pineal cyst in a girl with central precocious puberty.

Franzese A, Buongiovanni C, Belfiore G, Moggio G, Valerio G, Ciccarelli NP, Di Maio S.

Clin Pediatr (Phila). 1997 Sep;36(9):543-5. No abstract available.

PMID:
9307090
46.

Severe hypertrophic cardiomyopathy in an infant of a diabetic mother.

Franzese A, Valerio G, Ciccarelli NP, De Filippo G, Iannucci MP, Alfonsi L, Buono P, Farina V.

Diabetes Care. 1997 Apr;20(4):676-7. No abstract available.

PMID:
9097004

Supplemental Content

Loading ...
Support Center